1. Diekema, DJ, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. Journal of Clinical Microbiology 2003; 41: 3655–3660.
2. Bearman, GM, Wenzel, RP. Bacteremias: a leading cause of death. Archives of Medical Research 2005, 36: 646–659.
3. Madsen, KM, et al. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981–1994. APMIS 1999; 107: 346–352.
4. Douglas, MW, et al. Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Tropical Medicine and International Health 2004; 9: 795–804.
5. Laupland, KB, Church, DL, Gregson, DB. Blood cultures in ambulatory outpatients. BMC Infectious Disease 2005; 5: 35.
6. Pedersen, G, Schonheyder, HC, Sorensen, HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia – a Danish population-based cohort study from 1992 to 1997. Clinical and Microbial Infection 2003; 9: 793–802.
7. Okamoto, VN, Rubenfeld, GD. Attending to the lightness of numbers: toward the understanding of critical care epidemiology. Critical Care 2004; 8: 422–424.
8. Nimri, LF, Batchoun, R. Community-acquired bacteraemia in a rural area: predominant bacterial species and antibiotic resistance. Journal of Medical Microbiology 2004; 53: 1045–1049.
9. Jackson, LA, et al. Burden of community-onset Escherichia coli bacteremia in seniors. Journal of Infectious Diseases 2005; 191: 1523–1529.
10. Morin, CA, Hadler, JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. Journal of Infectious Diseases 2001; 184: 1029–1034.
11. Sofair, AN, et al. Epidemiology of community-onset candidemia in Connecticut and Maryland. Clinical Infectious Diseases 2006; 43: 32–39.
14. Laupland, KB. Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Critical Care 2004; 8: R431–436.
15. Pitout, JD, et al. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clinical Infectious Diseases 2004; 38: 1736–1741.
16. Laupland, KB, et al. Severe bloodstream infections: a population-based assessment. Critical Care Medicine 2004; 32: 992–997.
17. Gibb, AP, Hill, B, Chorel, B. Comparative study of BacT/Alert FAN bottles and standard BacT/Alert bottles. Diagnostic Microbiology and Infectious Disease 1998; 32: 159–163.
18. Laupland, KB, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105: E60.
19. Smellie, WS, Clark, G, McNulty, CA. Inequalities of primary care microbiology testing between hospital catchment areas. Journal of Clinical Pathology 2003, 56: 933–936.
20. Laupland, KB, et al. A population-based assessment of major trauma in a large Canadian region. American Journal of Surgery 2005; 189: 571–575; discussion 576.
21. Quan, H, et al. Acute myocardial infarction in Alberta: temporal changes in outcomes, 1994 to 1999. Canadian Journal of Cardiology 2004; 20: 213–219.
22. Field, TS, et al. Trends in hospital admission for stroke in Calgary. Canadian Journal of Neurological Sciences 2004; 31: 387–393.
23. Kyaw, MH, et al. Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiology and Infection 2002; 128: 139–147.
24. Hogg, GG, Strachan, JE, Lester, RA. Invasive pneumococcal disease in the population of Victoria. Medical Journal of Australia 2000; 173 (Suppl.) S32–35.
25. Campbell, JF, et al. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Medical Journal 1989; 48: 513–514, 517–518.
26. Laupland, KB, et al. Outpatient parenteral antibiotic therapy: evolution of the Calgary adult home parenteral therapy program. Clinical and Investigative Medicine 2002; 25: 185–190.